Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.22 USD | -10.09% | -9.71% | -27.88% |
05:44pm | UBS Cuts Price Target on Arrowhead Pharmaceuticals to $71 From $75, Keeps Buy Rating | MT |
May. 09 | Arrowhead Pharmaceuticals Swings to Loss in Fiscal Q2 | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- ARWR Stock
- News Arrowhead Pharmaceuticals, Inc.
- Official Publications